Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 17, 2020 Filed Jul 20, 2020 20:53 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
SaleCommon Stock | 18,174 | $80.01 | $1,454,096.29 |
DisclosureSEC source: 0001127602-20-021823 · form4.xml · nonDerivative · entry 3 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,577.138 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.0000 to $80.0450, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| July 17, 2020 Filed Jul 20, 2020 20:53 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
SaleCommon Stock | 18,111 | $80.00 | $1,448,880.00 |
DisclosureSEC source: 0001127602-20-021823 · form4.xml · nonDerivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,751.138 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 17, 2020 Filed Jul 20, 2020 20:53 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
Exercise / conversionCommon Stock | 18,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021823 · form4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,862.138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 16:33 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 420.2767 | $77.33 | $32,500.00 |
DisclosureSEC source: 0001127602-20-020746 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,963.9214 Underlying: Common Stock · 420.2767 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 16:42 UTC |
Seidman Christine EDirector
|
GrantPhantom Stock · Derivative | 210.1384 | $77.33 | $16,250.00 |
DisclosureSEC source: 0001127602-20-020747 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,837.9765 Underlying: Common Stock · 210.1384 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:11 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 387.9478 | $77.33 | $30,000.00 |
DisclosureSEC source: 0001127602-20-020796 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,156.5265 Underlying: Common Stock · 387.9478 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC |
LAVIZZO-MOUREY RISA JDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018482 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,477.7007 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:02 UTC |
Seidman Christine EDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018483 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,627.8381 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:07 UTC |
BRUN LESLIE ADirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018484 · form4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,618.5197 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:08 UTC |
Cech Thomas RDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018485 · form4.xml · derivative · entry 2 Cech Thomas R · CIK 0001464680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,238.0567 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:10 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018487 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,543.6447 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:11 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018489 · form4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,000.6407 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:12 UTC |
Rothman PaulDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018491 · form4.xml · derivative · entry 2 Rothman Paul · CIK 0001601332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,361.5907 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:14 UTC |
RUSSO PATRICIA FDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018492 · form4.xml · derivative · entry 2 RUSSO PATRICIA F · CIK 0001023219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,521.6197 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:15 UTC |
Craig Pamela J.Director
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018494 · form4.xml · derivative · entry 2 Craig Pamela J. · CIK 0001232910 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,361.5917 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:15 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018495 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,768.5787 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:16 UTC |
Warden Kathy JDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018496 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,591.502 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:43 UTC |
THULIN INGE GDirector
|
GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018502 · form4.xml · derivative · entry 2 Thulin Inge G · CIK 0001263739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,326.0257 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:48 UTC |
BRUN LESLIE ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $35.19 | $0.00 |
DisclosureSEC source: 0001127602-20-015779 · form4.xml · derivative · entry 3 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:48 UTC |
BRUN LESLIE ADirector
|
SaleCommon Stock | 5,000 | $75.46 | $377,300.00 |
DisclosureSEC source: 0001127602-20-015779 · form4.xml · nonDerivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,948 Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:48 UTC |
BRUN LESLIE ADirector
|
Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015779 · form4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:50 UTC |
WEEKS WENDELL PDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $35.19 | $0.00 |
DisclosureSEC source: 0001127602-20-015780 · form4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in equal installments on 08/04/2011, 08/04/2012 and 08/04/2013. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:50 UTC |
WEEKS WENDELL PDirector
|
SaleCommon Stock | 5,000 | $76.02 | $380,103.50 |
DisclosureSEC source: 0001127602-20-015780 · form4.xml · nonDerivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.0201 to $76.0250, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:50 UTC |
WEEKS WENDELL PDirector
|
Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015780 · form4.xml · nonDerivative · entry 1 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:14 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015653 · form4.xml · derivative · entry 7 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,345 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:14 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 1,020 | $76.86 | $78,397.20 |
DisclosureSEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 4 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,033.935 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:14 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 2,345 | $76.86 | $180,236.70 |
DisclosureSEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 3 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,053.935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:15 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015656 · form4.xml · derivative · entry 6 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,283 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:15 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Tax withholdingCommon Stock | 1,617 | $76.86 | $124,282.62 |
DisclosureSEC source: 0001127602-20-015656 · form4.xml · nonDerivative · entry 4 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,783.972 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:15 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionCommon Stock | 3,283 | $76.86 | $252,331.38 |
DisclosureSEC source: 0001127602-20-015656 · form4.xml · nonDerivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,400.972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:16 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · derivative · entry 6 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,290 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:16 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Tax withholdingCommon Stock | 458 | $76.86 | $35,201.88 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 4 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,846.334 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:16 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionCommon Stock | 1,290 | $76.86 | $99,149.40 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,304.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:17 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015658 · form4.xml · derivative · entry 7 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,752 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:17 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,848 | $76.86 | $142,037.28 |
DisclosureSEC source: 0001127602-20-015658 · form4.xml · nonDerivative · entry 4 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,763.106 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:17 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 3,752 | $76.86 | $288,378.72 |
DisclosureSEC source: 0001127602-20-015658 · form4.xml · nonDerivative · entry 3 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,611.106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:13 UTC |
Zachary JenniferEVP, General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015652 · form4.xml · derivative · entry 3 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,772 Underlying: Common Stock · 5,772 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:13 UTC |
Zachary JenniferEVP, General Counsel
|
Tax withholdingCommon Stock | 2,843 | $77.67 | $220,815.81 |
DisclosureSEC source: 0001127602-20-015652 · form4.xml · nonDerivative · entry 2 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,646.498 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:13 UTC |
Zachary JenniferEVP, General Counsel
|
Exercise / conversionCommon Stock | 5,772 | $77.67 | $448,311.24 |
DisclosureSEC source: 0001127602-20-015652 · form4.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,489.498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:14 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015653 · form4.xml · derivative · entry 6 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,298 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:14 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 565 | $77.67 | $43,883.55 |
DisclosureSEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 2 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,708.935 Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:14 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 1,298 | $77.67 | $100,815.66 |
DisclosureSEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 1 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,273.935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:15 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015656 · form4.xml · derivative · entry 5 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,212 Underlying: Common Stock · 1,212 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:15 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Tax withholdingCommon Stock | 597 | $77.67 | $46,368.99 |
DisclosureSEC source: 0001127602-20-015656 · form4.xml · nonDerivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,117.972 Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:15 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionCommon Stock | 1,212 | $77.67 | $94,136.04 |
DisclosureSEC source: 0001127602-20-015656 · form4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,714.972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:16 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · derivative · entry 5 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694 Underlying: Common Stock · 692 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:16 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Tax withholdingCommon Stock | 238 | $77.67 | $18,485.46 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,014.334 Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:16 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionCommon Stock | 692 | $77.67 | $53,747.64 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,252.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:17 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015658 · form4.xml · derivative · entry 6 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,906 Underlying: Common Stock · 1,904 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:17 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 938 | $77.67 | $72,854.46 |
DisclosureSEC source: 0001127602-20-015658 · form4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,859.106 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.